Insider Trading Alert - RPAI, SBUX, UGI, RRD And SGEN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 16, 2013, 116 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $164.25 to $16,145,446.22.

Highlighted Stocks Traded by Insiders:

Retail Properties of American (RPAI) - FREE Research Report

Imperiale Richard P who is Director at Retail Properties of American bought 3,000 shares at $12.79 on Dec. 16, 2013. Following this transaction, the Director owned 13,892 shares meaning that the stake was reduced by 27.54% with the 3,000-share transaction.

The shares most recently traded at $12.81, up $0.02, or 0.16% since the insider transaction. Historical insider transactions for Retail Properties of American go as follows:

  • 12-Week # shares bought: 6,800
  • 24-Week # shares bought: 6,800

The average volume for Retail Properties of American has been 1.4 million shares per day over the past 30 days. Retail Properties of American has a market cap of $3.0 billion and is part of the financial sector and real estate industry. Shares are up 6.6% year-to-date as of the close of trading on Monday.

Inland Western Retail Real Estate Trust, Inc. is a real estate investment trust. It engages in acquisition, development and management of properties. The trust invests in the real estate markets of United States. The stock currently has a dividend yield of 5.18%. Currently there are 2 analysts that rate Retail Properties of American a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RPAI - FREE

TheStreet Quant Ratings rates Retail Properties of American as a sell. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full Retail Properties of American Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Starbucks Corporation (SBUX) - FREE Research Report

Culver John who is group pres, CAP, Channel Dev at Starbucks Corporation sold 20,000 shares at $76.89 on Dec. 16, 2013. Following this transaction, the group pres, CAP, Channel Dev owned 123,317 shares meaning that the stake was reduced by 13.96% with the 20,000-share transaction.

The shares most recently traded at $76.02, down $0.87, or 1.14% since the insider transaction. Historical insider transactions for Starbucks Corporation go as follows:

  • 4-Week # shares sold: 61,828
  • 12-Week # shares sold: 61,828
  • 24-Week # shares sold: 68,884

The average volume for Starbucks Corporation has been 4.5 million shares per day over the past 30 days. Starbucks Corporation has a market cap of $57.5 billion and is part of the services sector and leisure industry. Shares are up 42.36% year-to-date as of the close of trading on Monday.

Starbucks Corporation operates as a roaster, marketer, and retailer of specialty coffee worldwide. Its stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single serve products, and juices and bottled water. The stock currently has a dividend yield of 1.36%. The company has a P/E ratio of 7635.0. Currently there are 17 analysts that rate Starbucks Corporation a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SBUX - FREE

TheStreet Quant Ratings rates Starbucks Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Starbucks Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UGI Corporation (UGI) - FREE Research Report

Athwal Davinder S who is Chief Accounting Officer at UGI Corporation bought 3,175 shares at $39.24 on Dec. 16, 2013. Following this transaction, the Chief Accounting Officer owned 8,032 shares meaning that the stake was reduced by 65.37% with the 3,175-share transaction.

The shares most recently traded at $39.77, up $0.53, or 1.33% since the insider transaction. Historical insider transactions for UGI Corporation go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 25,372
  • 24-Week # shares bought: 7,800
  • 24-Week # shares sold: 43,715

The average volume for UGI Corporation has been 517,600 shares per day over the past 30 days. UGI Corporation has a market cap of $4.5 billion and is part of the utilities sector and utilities industry. Shares are up 21.89% year-to-date as of the close of trading on Monday.

UGI Corporation distributes, stores, transports, and markets energy products and related services in the United States and internationally. The stock currently has a dividend yield of 2.84%. The company has a P/E ratio of 16.6. Currently there is 1 analyst that rates UGI Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UGI - FREE

TheStreet Quant Ratings rates UGI Corporation as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, revenue growth and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full UGI Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

R.R. Donnelley & Sons Company (RRD) - FREE Research Report

Coxhead Andrew B. who is Chief Accounting Officer at R.R. Donnelley & Sons Company sold 15,000 shares at $18.55 on Dec. 16, 2013. Following this transaction, the Chief Accounting Officer owned 106,413 shares meaning that the stake was reduced by 12.35% with the 15,000-share transaction.

The shares most recently traded at $18.41, down $0.14, or 0.76% since the insider transaction. Historical insider transactions for R.R. Donnelley & Sons Company go as follows:

  • 4-Week # shares sold: 50,000
  • 12-Week # shares sold: 102,323
  • 24-Week # shares sold: 117,323

The average volume for R.R. Donnelley & Sons Company has been 2.1 million shares per day over the past 30 days. R.R. Donnelley & Sons Company has a market cap of $3.5 billion and is part of the services sector and diversified services industry. Shares are up 111.35% year-to-date as of the close of trading on Monday.

R.R. Donnelley & Sons Company provides integrated communication solutions to private and public sectors worldwide. The stock currently has a dividend yield of 5.47%. Currently there is 1 analyst that rates R.R. Donnelley & Sons Company a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RRD - FREE

TheStreet Quant Ratings rates R.R. Donnelley & Sons Company as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full R.R. Donnelley & Sons Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Seattle Genetics (SGEN) - FREE Research Report

Baker Felix who is Director at Seattle Genetics bought 407,078 shares at $39.66 on Dec. 16, 2013. Following this transaction, the Director owned 361,052 shares meaning that the stake was reduced by 884.45% with the 407,078-share transaction.

The shares most recently traded at $39.28, down $0.38, or 0.97% since the insider transaction. Historical insider transactions for Seattle Genetics go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 102,000

The average volume for Seattle Genetics has been 872,500 shares per day over the past 30 days. Seattle Genetics has a market cap of $4.9 billion and is part of the health care sector and drugs industry. Shares are up 72.72% year-to-date as of the close of trading on Monday.

Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product candidate, ADCETRIS, has accelerated approval form the U.S. Currently there are 3 analysts that rate Seattle Genetics a buy, 2 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SGEN - FREE

TheStreet Quant Ratings rates Seattle Genetics as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and feeble growth in its earnings per share. Get the full Seattle Genetics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%